Research Presentation Session

The next generation of prostate interventions using state-of-the-art imaging techniques

Lectures

1
RPS 107 - Remote-controlled manipulated transrectal biopsy of the prostate: a promising technique

RPS 107 - Remote-controlled manipulated transrectal biopsy of the prostate: a promising technique

05:30R. Van Stiphout, Roermond / NL

2
RPS 107 - MR directed biopsy (MRDB) for prostate cancer detection: in-bore vs MR-transrectal ultrasound fusion technique, performed by the same operators

RPS 107 - MR directed biopsy (MRDB) for prostate cancer detection: in-bore vs MR-transrectal ultrasound fusion technique, performed by the same operators

04:48E. Messina, Rome / IT

3
RPS 107 - In-bore MRI-guided prostate biopsy in a patient group with a high likelihood of mpMRI findings: a single centre experience

RPS 107 - In-bore MRI-guided prostate biopsy in a patient group with a high likelihood of mpMRI findings: a single centre experience

05:35S. Durmaz, Istanbul / TR

4
RPS 107 - Reasons for missing clinically significant prostate cancer by targeted magnetic resonance imaging/ultrasound fusion-guided biopsy

RPS 107 - Reasons for missing clinically significant prostate cancer by targeted magnetic resonance imaging/ultrasound fusion-guided biopsy

05:10M. Klingebiel, Düsseldorf / DE

5
RPS 107 - MRI and clinical validation of transperineal laser ablation of benign prostatic hyperplasia in outpatient settings: an alternative effective treatment suitable for the COVID-19 outbreak

RPS 107 - MRI and clinical validation of transperineal laser ablation of benign prostatic hyperplasia in outpatient settings: an alternative effective treatment suitable for the COVID-19 outbreak

04:51C. Ryan, Rome / IT

6
RPS 107 - Rates of infection post-MRI guided target trans-rectal prostate biopsy (TRUS) during the COVID-19 pandemic

RPS 107 - Rates of infection post-MRI guided target trans-rectal prostate biopsy (TRUS) during the COVID-19 pandemic

06:50P. Tansey, Dublin / IE

RPS 107-2
5 min
Remote-controlled manipulated transrectal biopsy of the prostate: a promising technique
Rogier Van Stiphout, Roermond / Netherlands
RPS 107-3
5 min
MR directed biopsy (MRDB) for prostate cancer detection: in-bore vs MR-transrectal ultrasound fusion technique, performed by the same operators
Emanuele Messina, Rome / Italy
RPS 107-4
5 min
In-bore MRI-guided prostate biopsy in a patient group with a high likelihood of mpMRI findings: a single centre experience
Selahattin Durmaz, Istanbul / Turkey
RPS 107-5
5 min
Reasons for missing clinically significant prostate cancer by targeted magnetic resonance imaging/ultrasound fusion-guided biopsy
Maximilian Klingebiel, Düsseldorf / Germany
RPS 107-6
5 min
MRI and clinical validation of transperineal laser ablation of benign prostatic hyperplasia in outpatient settings: an alternative effective treatment suitable for the COVID-19 outbreak
Colleen Ryan, Rome / Italy
RPS 107-7
5 min
Rates of infection post-MRI guided target trans-rectal prostate biopsy (TRUS) during the COVID-19 pandemic
Paul Tansey, Dublin / Ireland
25 min
Live Q&A